We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+4.67%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.05B
AUM Growth
+$276M
(+4.1%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
27.96%
Holding
1,430
New
433
Increased
334
Reduced
305
Closed
319
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$182M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$170M |
| 3 |
AET
Aetna Inc
AET
|
+$131M |
| 4 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$108M |
| 5 |
Brookdale Senior Living
BKD
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$435M |
| 2 |
Elevance Health
ELV
|
+$121M |
| 3 |
Cigna
CI
|
+$119M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$82.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$72.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.34% |
| 2 | Financials | 7.86% |
| 3 | Consumer Discretionary | 7.17% |
| 4 | Technology | 6.32% |
| 5 | Industrials | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HES
951
DELISTED
Hess
HES
| $211K | ﹤0.01% |
3,149
-16,171
| -84% | -$1.15M |
|
952
Hartford Financial Services
HIG
$38.9B
| $210K | ﹤0.01% |
5,041
-223,727
| -98% | -$9.34M |
|
953
Broadridge
BR
$17.8B
| $209K | ﹤0.01% |
+4,176
| New | +$222K |
|
|
ACHN
954
DELISTED
Achillion Pharmaceuticals
ACHN
| $209K | ﹤0.01% |
23,614
-2,400
| -9% | -$22.7K |
|
|
ELLI
955
DELISTED
Ellie Mae Inc
ELLI
| $209K | ﹤0.01% |
+3,000
| New | +$187K |
|
|
ABCO
956
DELISTED
Advisory Board Co
ABCO
| $209K | ﹤0.01% |
+3,825
| New | +$197K |
|
957
PepsiCo
PEP
$190B
| $207K | ﹤0.01% |
+2,216
| New | +$212K |
|
958
American Homes 4 Rent
AMH
$12B
| $206K | ﹤0.01% |
+12,850
| New | +$216K |
|
|
SFLY
959
DELISTED
Shutterfly, Inc.
SFLY
| $206K | ﹤0.01% |
4,300
-3,143
| -42% | -$146K |
|
960
COPT Defense Properties
CDP
$4.3B
| $204K | ﹤0.01% |
+8,649
| New | +$230K |
|
|
AVID
961
DELISTED
Avid Technology Inc
AVID
| $204K | ﹤0.01% |
+15,257
| New | +$244K |
|
962
Korn Ferry
KFY
$4.18B
| $203K | ﹤0.01% |
+5,834
| New | +$193K |
|
|
UNT
963
DELISTED
UNIT Corporation
UNT
| $203K | ﹤0.01% |
+7,500
| New | +$236K |
|
|
FGL
964
DELISTED
Fidelity & Guaranty Life
FGL
| $203K | ﹤0.01% |
8,600
-2,200
| -20% | -$49.5K |
|
|
BLUE
965
DELISTED
bluebird bio
BLUE
| $202K | ﹤0.01% |
+93
| New | +$189K |
|
966
Motorola Solutions
MSI
$72.3B
| $202K | ﹤0.01% |
+3,520
| New | +$211K |
|
967
Kite Realty
KRG
$5.81B
| $201K | ﹤0.01% |
+8,200
| New | +$221K |
|
968
Lincoln National
LNC
$8.73B
| $201K | ﹤0.01% |
3,401
-1,076
| -24% | -$63K |
|
969
Service Corp International
SCI
$11.7B
| $201K | ﹤0.01% |
+6,831
| New | +$194K |
|
970
Sonoco
SON
$5.57B
| $200K | ﹤0.01% |
+4,671
| New | +$210K |
|
|
PLKI
971
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
| $200K | ﹤0.01% |
+3,342
| New | +$193K |
|
972
Knowles
KN
$3.13B
| $199K | ﹤0.01% |
+11,020
| New | +$214K |
|
973
St. Joe Company
JOE
$3.54B
| $194K | ﹤0.01% |
+12,468
| New | +$209K |
|
|
IMGN
974
DELISTED
Immunogen Inc
IMGN
| $190K | ﹤0.01% |
13,215
-11,985
| -48% | -$132K |
|
975
Nektar Therapeutics
NKTR
$2.39B
| $189K | ﹤0.01% |
1,010
-1,206
| -54% | -$208K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Visium Asset Management held 1,430 positions worth $7.05B, up 4.1% from $6.78B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management's Q2 2015 filing shows 433 new, 334 increased, 305 reduced and 319 closed positions. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M. The largest sale was Allergan plc, an estimated $435M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
- Visium Asset Management's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M.
- Visium Asset Management added most to Bausch Health in Q2 2015, an estimated $182M increase.
- Visium Asset Management's biggest Q2 2015 reduction was Elevance Health, cutting an estimated $121M.
- Visium Asset Management fully exited Allergan plc in Q2 2015, selling an estimated $435M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.05B portfolio in Q2 2015.
- Visium Asset Management opened 433 new positions and closed 319 in Q2 2015.
- Visium Asset Management's portfolio value rose 4.1% quarter-over-quarter to $7.05B.
Based on Visium Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.